Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Monitored Therapeutics
AddedFeb 15, 2024
UpdatedJun 18, 2026
Monitored Therapeutics

Monitored Therapeutics

Monitored Therapeutics Inc. offers remote patient monitoring solutions for managing respiratory diseases.

HQ
Dublin, OH, US
Founded
2011
Overview
Compare
Fundraising
Employees
Website

Monitored Therapeutics Inc. was founded with the mission to enhance the management of respiratory diseases through advanced remote patient monitoring solutions. The company envisions a healthcare landscape where real-time insights and analytics significantly improve patient outcomes. Their core products include lab-quality spirometry and other physiological data collection tools, which are designed for both decentralized clinical trials and routine healthcare provider use. Monitored Therapeutics primarily focuses on providing high-quality, remote monitoring solutions that reduce variability and increase the reliability of respiratory health data.

Notable affiliated people and investors in Monitored Therapeutics include key figures in the healthcare and technology sectors, though specific names are not publicly highlighted. The company has achieved significant milestones in improving patient care through its innovative remote monitoring technologies, which have been integrated into various clinical trials and healthcare settings. Overall, Monitored Therapeutics has made a substantial impact by enabling more accurate and consistent respiratory health monitoring, thereby contributing to better disease management and patient outcomes.

Monitored Therapeutics - Quick Facts

When was Monitored Therapeutics founded?

Monitored Therapeutics was founded in 2011.

Where is Monitored Therapeutics' headquarters located?

Monitored Therapeutics' headquarters is located in Dublin, OH, US.

When was Monitored Therapeutics' last funding round?

Monitored Therapeutics' most recent funding round was for $4.3M (USD) in July 2021.

How much has Monitored Therapeutics raised to-date?

As of Jul 27, 2021, Monitored Therapeutics has raised a total of $5.9M (USD).

How many employees does Monitored Therapeutics have?

Monitored Therapeutics has 27 employees as of Feb 5, 2024.

Monitored Therapeutics - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • Analytics
  • Telemedicine
Geographic Exposure
  • United States
Model
  • Platform
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Patient Monitoring
Tags
  • Healthcare
  • Healthtech
  • SaaS
NAICS
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 8 more industry codes
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research